128 related articles for article (PubMed ID: 38355400)
21. Cell death induction and intracellular vesicle formation in human colorectal cancer cells treated with Δ
Hwang YN; Kwon IS; Park JH; Na HH; Kwon TH; Park JS; Kim KC
Genes Genomics; 2023 Dec; 45(12):1463-1474. PubMed ID: 37837516
[TBL] [Abstract][Full Text] [Related]
22. Norlignans and phenolics from genus Curculigo protect corticosterone-injured neuroblastoma cells SH-SY5Y by inhibiting endoplasmic reticulum stress-mitochondria pathway.
Wang Y; Liu Z; Wei J; Di L; Wang S; Wu T; Li N
J Ethnopharmacol; 2022 Oct; 296():115430. PubMed ID: 35659626
[TBL] [Abstract][Full Text] [Related]
23. Suppression of experimental autoimmune encephalomyelitis by cannabinoids.
Wirguin I; Mechoulam R; Breuer A; Schezen E; Weidenfeld J; Brenner T
Immunopharmacology; 1994; 28(3):209-14. PubMed ID: 7852052
[TBL] [Abstract][Full Text] [Related]
24. Separation of the discriminative stimulus effects of stereoisomers of delta 2- and delta 3-tetrahydrocannabinols in pigeons.
Jrbe TU; Hiltunen AJ; Mechoulam R; Srebnik M; Breuer A
Eur J Pharmacol; 1988 Nov; 156(3):361-6. PubMed ID: 2850933
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells.
Turkanis SA; Karler R; Partlow LM
Brain Res; 1991 Sep; 560(1-2):245-50. PubMed ID: 1662110
[TBL] [Abstract][Full Text] [Related]
26. Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.
Azad SC; Marsicano G; Eberlein I; Putzke J; Zieglgänsberger W; Spanagel R; Lutz B
Eur J Neurosci; 2001 Feb; 13(3):561-8. PubMed ID: 11168564
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.
Wiley JL; Huffman JW; Balster RL; Martin BR
Drug Alcohol Depend; 1995 Nov; 40(1):81-6. PubMed ID: 8746928
[TBL] [Abstract][Full Text] [Related]
28. Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.
Fishbein M; Gov S; Assaf F; Gafni M; Keren O; Sarne Y
Exp Brain Res; 2012 Sep; 221(4):437-48. PubMed ID: 22821081
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
Chen J; Lee CT; Errico S; Deng X; Cadet JL; Freed WJ
Brain Res Mol Brain Res; 2005 Apr; 134(2):215-25. PubMed ID: 15836919
[TBL] [Abstract][Full Text] [Related]
31. Enantioseparation of chiral phytocannabinoids in medicinal cannabis.
Russo F; Tolomeo F; Angela Vandelli M; Biagini G; Laganà A; Laura Capriotti A; Cerrato A; Carbone L; Perrone E; Cavazzini A; Maiorano V; Gigli G; Cannazza G; Citti C
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123682. PubMed ID: 36965450
[TBL] [Abstract][Full Text] [Related]
32. The long-term effects of Δ
Gholami D; Noori AR; Mohammadkhani M; Emruzi Z; Riazi GH
Arch Biochem Biophys; 2020 Oct; 693():108574. PubMed ID: 32898566
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective Effects of 1,2-Diarylpropane Type Phenylpropanoid Enantiomers from Red Raspberry against H
Zhou L; Yao GD; Song XY; Wang J; Lin B; Wang XB; Huang XX; Song SJ
J Agric Food Chem; 2018 Jan; 66(1):331-338. PubMed ID: 29215880
[TBL] [Abstract][Full Text] [Related]
34. Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells.
Cabral GA; McNerney PJ; Mishkin EM
Arch Toxicol; 1987 Aug; 60(6):438-49. PubMed ID: 2821958
[TBL] [Abstract][Full Text] [Related]
35. Differential Enantiomer-Specific Signaling of Cannabidiol at CB
Bosquez-Berger T; Wilson S; Iliopoulos-Tsoutsouvas C; Jiang S; Wager-Miller J; Nikas SP; Mackie KP; Makriyannis A; Straiker A
Mol Pharmacol; 2022 Dec; 102(6):259-268. PubMed ID: 36153039
[TBL] [Abstract][Full Text] [Related]
36. Δ
Banaszkiewicz M; Tarwacka P; Krzywonos-Zawadzka A; Olejnik A; Laprairie R; Noszczyk-Nowak A; Sawicki G; Bil-Lula I
Front Biosci (Landmark Ed); 2022 Apr; 27(4):114. PubMed ID: 35468673
[TBL] [Abstract][Full Text] [Related]
37. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
38. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
39. The suppressive effect of delta-1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture.
Lewysohn O; Cordova T; Nimrod A; Ayalon D
Horm Res; 1984; 19(1):43-51. PubMed ID: 6319259
[TBL] [Abstract][Full Text] [Related]
40. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.
Balster RL; Prescott WR
Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
